Loading clinical trials...

Osteofibrous Dysplasia (Kempson-Campanacci's Disease) | Clinical Trials | Clareo Health

COMPLETEDNCT04104763

Osteofibrous Dysplasia (Kempson-Campanacci's Disease)

The aim of the present study is to obtain long term follow-up in patients with osteofibrous dysplasia, to assess natural history of the disease, late results of treatment and in particular the potenti...

Lead sponsor: Istituto Ortopedico Rizzoli•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment50

Start dateAug 2019

Last updatedAug 23, 2022

Condition

Osteofibrous Dysplasia

Locations shown

Dept. of Pathology of IRCCS Istituto Ortopedico Rizzoli

Bologna

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 23, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions